Comparing the Efficacy and Safety of a New Additional Treatment With Tislelizumab in Non-Small Cell Lung Cancer (NSCLC)
BeOne Medicines
BeOne Medicines
Synthekine
BeOne Medicines
Boehringer Ingelheim
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
Janssen Research & Development, LLC
Gilead Sciences
BioNTech SE
Bristol-Myers Squibb
Genmab
Merck Sharp & Dohme LLC
Merck Sharp & Dohme LLC
Shanghai JMT-Bio Inc.
AstraZeneca
AstraZeneca
Xencor, Inc.
Merck Sharp & Dohme LLC
Merck Sharp & Dohme LLC
Eli Lilly and Company
Pfizer
Mirati Therapeutics Inc.
Eli Lilly and Company
Hoffmann-La Roche
AstraZeneca
Hoffmann-La Roche
AstraZeneca
Merck Sharp & Dohme LLC
Incyte Corporation
Merck Sharp & Dohme LLC
Arcus Biosciences, Inc.
Akeso
Revolution Medicines, Inc.
Verastem, Inc.
AstraZeneca
Hoffmann-La Roche
RemeGen Co., Ltd.
Akeso
AstraZeneca
Summit Therapeutics
Bristol-Myers Squibb
InxMed (Shanghai) Co., Ltd.
AstraZeneca
AstraZeneca
Bayer
AbbVie
Janssen Research & Development, LLC
Pfizer
Bristol-Myers Squibb
AstraZeneca
Regeneron Pharmaceuticals